Innoviva (INVA) Change in Cash (2010 - 2026)
Innoviva posted quarterly Change in Cash of $52.1 million for Q1 2026, up 269.13% year-on-year from $14.1 million in Q1 2025, and down 69.6% on a QoQ basis from $171.5 million in Q3 2025.
Innoviva (INVA) has 17 years of Change in Cash data on file, last reported at $52.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 269.13% year-over-year to $52.1 million; the trailing twelve-month figure through Mar 2026 stood at $316.3 million (up 201.97% YoY), and the FY2025 full-year result was $246.0 million, up 120.7% from the prior year.
- Change in Cash for Q1 2026 stood at $52.1 million, down from $171.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $171.5 million in Q3 2025 and bottomed at -$147.0 million in Q1 2023.
- The 5-year median for Change in Cash is $38.6 million (2024), against an average of $27.6 million.
- The widest annual swing landed in 2023, when Change in Cash sank 1062.23%; it then jumped 269.13% in 2026.
- A 5-year view of Change in Cash shows it stood at $99.3 million in 2022, then sank by 211.83% to -$111.1 million in 2023, then soared by 160.44% to $67.1 million in 2024, then jumped by 155.6% to $171.5 million in 2025, then plunged by 69.6% to $52.1 million in 2026.
- The last three Change in Cash figures came in at $52.1 million (Q1 2026), $171.5 million (Q3 2025), and $78.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 52.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.14 Mn |
| Sep 30, 2025 | 171.55 Mn |
| Jun 30, 2025 | 78.44 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Sep 30, 2024 | 67.12 Mn |
| Jun 30, 2024 | 38.65 Mn |
| Mar 31, 2024 | -15.16 Mn |
| Sep 30, 2023 | -111.05 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Mar 31, 2023 | -147.00 Mn |
| Sep 30, 2022 | 99.30 Mn |
| Jun 30, 2022 | 66.78 Mn |
| Mar 31, 2022 | 15.28 Mn |
| Sep 30, 2021 | -111.37 Mn |
| Jun 30, 2021 | -239.63 Mn |
| Mar 31, 2021 | 36.40 Mn |
| Dec 31, 2020 | -232.71 Mn |
| Sep 30, 2020 | 66.05 Mn |
| Jun 30, 2020 | 61.17 Mn |
| Mar 31, 2020 | 73.89 Mn |
| Dec 31, 2019 | 105.15 Mn |
| Sep 30, 2019 | 30.99 Mn |
| Jun 30, 2019 | 76.80 Mn |
| Mar 31, 2019 | 2.73 Mn |
| Dec 31, 2018 | 13.80 Mn |
| Sep 30, 2018 | -38.61 Mn |
| Jun 30, 2018 | 60.09 Mn |
| Mar 31, 2018 | -46.20 Mn |
| Dec 31, 2017 | -65.08 Mn |
| Sep 30, 2017 | 10.78 Mn |
| Jun 30, 2017 | -32.17 Mn |
| Mar 31, 2017 | 41.79 Mn |
| Dec 31, 2016 | 24.82 Mn |
| Sep 30, 2016 | -19.75 Mn |
| Jun 30, 2016 | -38.83 Mn |
| Mar 31, 2016 | -7.40 Mn |
| Dec 31, 2015 | 80.43 Mn |
| Sep 30, 2015 | -70.83 Mn |
| Jun 30, 2015 | 8.39 Mn |
| Mar 31, 2015 | 44.39 Mn |
| Dec 31, 2014 | -22.78 Mn |
| Sep 30, 2014 | -88.48 Mn |
| Jun 30, 2014 | 82.78 Mn |
| Mar 31, 2014 | -18.24 Mn |
| Dec 31, 2013 | -28.38 Mn |
| Sep 30, 2013 | -27.35 Mn |
| Jun 30, 2013 | -66.83 Mn |
| Mar 31, 2013 | 171.22 Mn |
| Dec 31, 2012 | -17.39 Mn |
| Sep 30, 2012 | -48.86 Mn |
| Jun 30, 2012 | 146.79 Mn |
| Mar 31, 2012 | -30.47 Mn |
| Dec 31, 2011 | -17.96 Mn |
| Sep 30, 2011 | -27.92 Mn |
| Jun 30, 2011 | -57.22 Mn |
| Mar 31, 2011 | -15.46 Mn |
| Dec 31, 2010 | 100.23 Mn |
| Sep 30, 2010 | -6.62 Mn |